|
1
|
Boggild A, Brophy J, Charlebois P, Crockett M, Geduld J, Ghesquiere W, McDonald P, Plourde P, Teitelbaum P, Tepper M, Schofield S, McCarthy A. Summary of recommendations on malaria issues in special hosts. CANADA COMMUNICABLE DISEASE REPORT = RELEVE DES MALADIES TRANSMISSIBLES AU CANADA 2014; 40:178-191. [PMID: 29769841 PMCID: PMC5864471 DOI: 10.14745/ccdr.v40i10a02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND On behalf of the Public Health Agency of Canada, the Committee to Advise on Tropical Medicine and Travel (CATMAT) developed the Canadian Recommendations for the Prevention and Treatment of Malaria Among International Travellers for Canadian health care providers who are preparing patients for travel to malaria-endemic areas and treating travellers who have returned ill. OBJECTIVE To provide guidelines on malaria issues related to special hosts. METHODS CATMAT reviewed all major sources of information on malaria prevention, as well as recent research and national and international epidemiological data, to tailor guidelines to the Canadian context. The evidence-based medicine recommendations were developed with associated rating scales for the strength and quality of the evidence. RECOMMENDATIONS All people visiting malaria endemic regions should use effective personal protective measures (PPM; topical repellants, bed nets, behavioural choices) and the prescribed chemoprophylaxis. Chemoprophylaxis for pregnant and breastfeeding women and for children requires careful consideration in the context of the pregnancy trimester, the age or size of the infant/child as well as their glucose-6-phosphate dehydrogenase (G6PD) status. Recommendations for long-term travellers, expatriates and people visiting friends and relatives (VFRs) do not differ markedly from those for short-term travellers. Some underlying medical conditions may make individuals more vulnerable to malaria. In addition, some conditions or their treatment may preclude the use of one or more antimalarial medications.
Collapse
Affiliation(s)
- by the Committee to Advise on Tropical Medicine and Travel (CATMAT)
- University Health Network, Toronto General Hospital, Toronto, Ontario
- Division of Infectious Diseases, Children’s Hospital of Eastern Ontario, Ottawa, Ontario
- Internal Medicine, Canadian Forces Health Services Centre (Atlantic), Halifax, Nova Scotia
- Paediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba
- Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Ottawa, Ontario
- Infectious Diseases and Internal Medicine, University of British Columbia, Victoria, British Columbia
- Therapeutic Products Directorate, Health Canada, Ottawa, Ontario
- Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba
- Riverside Travel Medicine Clinic, Ottawa, Ontario
- Communicable Disease Control Program, Directorate of Force Health Protection (Ottawa, Ontario)
- Pest Management Entomology, Directorate of Force Health Protection, Ottawa, Ontario
- Tropical Medicine and International Health Clinic, Division of Infectious Disease, Ottawa Hospital General Campus, Ottawa, Ontario
| | - A Boggild
- University Health Network, Toronto General Hospital, Toronto, Ontario
| | - J Brophy
- Division of Infectious Diseases, Children’s Hospital of Eastern Ontario, Ottawa, Ontario
| | - P Charlebois
- Internal Medicine, Canadian Forces Health Services Centre (Atlantic), Halifax, Nova Scotia
| | - M Crockett
- Paediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba
| | - J Geduld
- Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Ottawa, Ontario
| | - W Ghesquiere
- Infectious Diseases and Internal Medicine, University of British Columbia, Victoria, British Columbia
| | - P McDonald
- Therapeutic Products Directorate, Health Canada, Ottawa, Ontario
| | - P Plourde
- Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba
| | - P Teitelbaum
- Riverside Travel Medicine Clinic, Ottawa, Ontario
| | - M Tepper
- Communicable Disease Control Program, Directorate of Force Health Protection (Ottawa, Ontario)
| | - S Schofield
- Pest Management Entomology, Directorate of Force Health Protection, Ottawa, Ontario
| | - A McCarthy
- Tropical Medicine and International Health Clinic, Division of Infectious Disease, Ottawa Hospital General Campus, Ottawa, Ontario
| |
Collapse
|
|
2
|
Ollivier L, Michel R, Carlotti MP, Mahé P, Romand O, Todesco A, Migliani R, Boutin JP. Chemoprophylaxis compliance in a French battalion after returning from malaria-endemic area. J Travel Med 2008; 15:355-7. [PMID: 19006510 DOI: 10.1111/j.1708-8305.2008.00219.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Incidence of malaria is increasing in travelers and soldiers. In 2006, a survey was performed in a French battalion returning from a malaria-endemic area. According to the chemoprophylaxis plasma concentration and the individuals' reports, the noncompliance rates were high, respectively, 63.4 and 54.7%.
Collapse
Affiliation(s)
- Lénaïck Ollivier
- Département d'épidémiologie et de santé publique, Institut de médecine tropicale du Service de santé des armées, BL 46, Marseille 13998, France.
| | | | | | | | | | | | | | | |
Collapse
|